Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Johnson & Johnson to resume Covid-19 vaccine roll-out in Europe after EMA review
Pharmaceutical Business Review
Wed, 04/21/21 - 10:38 am
JNJ
vaccines
COVID-19
Europe
blood clots
Will Regeneron's COVID Cocktail Win Be Short-Lived?
Motley Fool
Wed, 04/21/21 - 10:37 am
Regeneron
antibodies
COVID-19
U.S. CDC expands COVID-19 vaccine eligibility to 16 and older
Reuters
Wed, 04/21/21 - 10:32 am
COVID-19
vaccines
CDC
Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
NIH
Wed, 04/21/21 - 10:31 am
NIH
clinical trials
drug repurposing
COVID-19
The next 2 months in biotech and pharma will be busy. Here's what to watch.
BioPharma Dive
Tue, 04/20/21 - 11:16 pm
Biogen
aducanumab
FDA
Vertex Pharmaceuticals
Sarepta Therapeutics
JNJ
AstraZeneca
vaccines
COVID-19
Abbott Profits Triple As Over-the-counter Covid-19 Tests Hit Drugstore Shelves
Forbes
Tue, 04/20/21 - 11:11 am
Abbott Labs
COVID-19
earnings
diagnostics
A top analyst sees Pfizer and Moderna seizing a $38B prize as safety frets sideline global vaccine players
Endpoints
Tue, 04/20/21 - 11:10 am
Pfizer
Moderna Therapeutics
COVID-19
vaccines
JNJ
AstraZeneca
How Johnson & Johnson Beat Expectations in Q1
Motley Fool
Tue, 04/20/21 - 11:09 am
JNJ
earnings
COVID-19
vaccines
PPD-backed siteless trial specialist Medable reels in $78M as the pandemic continues to push its biz forward
Fierce Biotech
Tue, 04/20/21 - 11:08 am
Medable
COVID-19
pandemic
funding
decentralized clinical trials
clinical trials
PPD
EMA to add safety warning to J&J Covid-19 vaccine over rare blood clots
Endpoints
Tue, 04/20/21 - 10:58 am
EMA
Europe
JNJ
vaccines
blood clots
COVID-19
Half of US adults have received at least one COVID-19 vaccine dose
Beckers Hospital Review
Mon, 04/19/21 - 10:26 pm
vaccines
COVID-19
Serum Institute nears $400M grant to boost AstraZeneca COVID shot production—just as material shortages mount
Fierce Pharma
Mon, 04/19/21 - 10:19 pm
Serum Institute
AstraZeneca
COVID-19
vaccines
Fauci Says J&J Vaccine Likely to Resume by Friday
BioSpace
Mon, 04/19/21 - 10:18 pm
JNJ
vaccines
COVID-19
Anthony Fauci
The Moderna CEO's Bold Statement That May Mean Bad News for Novavax
Motley Fool
Mon, 04/19/21 - 11:23 am
Moderna Therapeutics
Novavax
Pharma CEOs
vaccines
COVID-19
Stephane Bancel
flu vaccines
Q&A with Acting FDA Commissioner Janet Woodcock on the Future of the FDA
BioSpace
Mon, 04/19/21 - 11:19 am
FDA
COVID-19
Janet Woodcock
FDA orders shutdown at Emergent's troubled plant 2 weeks after handing J&J the keys
Fierce Pharma
Mon, 04/19/21 - 11:16 am
Emergent BioSolutions
drug manufacturing
vaccines
FDA
COVID-19
Adagio raises a monster $336M round for bespoke COVID-19 drug battle
Fierce Biotech
Mon, 04/19/21 - 11:14 am
Adagio Therapeutics
COVID-19
South African variant may 'break through' Pfizer vaccine protection, but vaccine highly effective, Israeli study says
Yahoo/Reuters
Sun, 04/18/21 - 11:35 pm
COVID-19
Pfizer
vaccines
BioNTech
COVID-19 variants
Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles
Fierce Pharma
Sun, 04/18/21 - 12:07 am
Moderna Therapeutics
vaccines
COVID-19
UK
Canada
Europe
Pfizer CEO: Third COVID-19 Vaccine Dose Will Likely Be Needed Within 12 Months
BioSpace
Fri, 04/16/21 - 09:59 am
Pfizer
vaccines
COVID-19
Albert Bourla
Pharma CEOs
Pages
« first
‹ previous
…
74
75
76
77
78
79
80
81
82
…
next ›
last »